Shanghai Bao Pharmaceuticals shines in Hong Kong debut

Shanghai Bao Pharmaceuticals Co

10/12/2025 02:46

** Shares of Shanghai Bao Pharmaceuticals 2659.HK rise as much as 132.8% from the offer price to HK$61.4 each in Hong Kong debut on Wednesday, outpacing a 0.4% slip in the benchmark Hang Seng Index .HSI

** Stock later trims gains to HK$57.95, still up 119.7% from HK$26.38 apiece offer price with 5.59 million shares worth HK$307 million ($39.45 million) changing hands

** The China-based pharmaceutical products developer sold 37.91 million shares in a global offering, raising HK$992 million ($127.48 million) for R&D and commercialization of core products, and to fund clinical trials, among others

** Subscription level of the Hong Kong public offering portion was 3,526.34 times, and the international portion was 6.59 times

($1 = 7.7815 Hong Kong dollars)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))